Search - tctmd.com

Displaying 961 - 980 of 1215

Sort: Relevancy | Date

News Features

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 07, 2012

News Daily News

New Oral Anticoagulants Top Warfarin in A-fib Stroke Prevention

May 04, 2012

News Daily News

French Registry Provides Window into Real-World TAVR Use

Caitlin E. Cox

May 03, 2012

News Industry News

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

April 27, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Daily News

SVS Registry Finds Surgery Superior to Stenting in Older Carotid Patients

Caitlin E. Cox

April 23, 2012

News Daily News

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

April 19, 2012

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Daily News

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Caitlin E. Cox

April 05, 2012

News Daily News

Baseline Anemia Raises Risk for Stent Thrombosis After DES

L.A. McKeown

April 04, 2012

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

News Daily News

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Jason Kahn

April 03, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

Caitlin E. Cox

March 30, 2012

Presentation

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Presenter: 53202|Dean Kereiakes

March 28, 2012

News Conference News ACC 2012

Early Cardiac CTA Improves Decision-Making in Suspected ACS

L.A. McKeown

March 27, 2012

News Conference News ACC 2012

ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease

Yael L. Maxwell

March 27, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

Advertisement

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

New Oral Anticoagulants Top Warfarin in A-fib Stroke Prevention

French Registry Provides Window into Real-World TAVR Use

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

SVS Registry Finds Surgery Superior to Stenting in Older Carotid Patients

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Baseline Anemia Raises Risk for Stent Thrombosis After DES

PRODIGY Published: No Advantage to Long-term Clopidogrel

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Early Cardiac CTA Improves Decision-Making in Suspected ACS

ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content